Expand SGMT Menu
SGMT MENU

SGMT Stock Posts


Unusual Option Volume

SGMT Sagimet Biosciences - Series A8.94-0.20 (-2.2%)

Sagimet Biosciences - Series A trades 10,396 contracts.
View Details...
Unusual Option Volume

SGMT Sagimet Biosciences - Series A9.02-1.40 (-13.4%)

Sagimet Biosciences - Series A trades 2,772 contracts.
View Details...
Unusual Option Volume

SGMT Sagimet Biosciences - Series A9.48+0.09 (+1.0%)

Sagimet Biosciences - Series A trades 4,140 contracts. News: Sagimet Biosciences Receives FDA 'Study May Proceed' Letter and IND Clearance for Phase 3 Trial in Acne in Adolescent and Adult Patients
View Details...
Unusual Option Volume

SGMT Sagimet Biosciences - Series A8.26+2.40 (+41.0%)

Sagimet Biosciences - Series A trades 2,712 contracts. The company has the following event: KOL event and webcast to discuss planned development of denifanstat for acne on Apr 30, 2026. News: Sagimet Biosciences Announces Pricing of $175.0 Million Underwritten Offering of Series A Common Stock
View Details...
Unusual Option Volume

SGMT Sagimet Biosciences - Series A6.22+0.26 (+4.4%)

Sagimet Biosciences - Series A trades 2,556 contracts.
View Details...
Unusual Option Volume

SGMT Sagimet Biosciences - Series A9.43+0.82 (+9.5%)

Sagimet Biosciences - Series A trades 2,648 contracts. The company has the following event: A New Mechanism of Action in Treating Acne: Update on Positive Phase 3 Denifanstat Trial for the Treatment of Moderate to Severe Acne on Jun 16, 2025.
View Details...
Load Earlier Posts
Market Data Delayed 15 Minutes